{
    "2018-10-19": [
        [
            {
                "time": "",
                "original_text": "贵州百灵混改正式落地，斥资7亿能否实现做大国企的目标？",
                "features": {
                    "keywords": [
                        "贵州百灵",
                        "混改",
                        "落地",
                        "7亿"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "国企改革"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "贵州百灵参与国企混改项目落地，拟投7亿元持云南植物药业40%股份",
                "features": {
                    "keywords": [
                        "贵州百灵",
                        "国企混改",
                        "云南植物药业",
                        "40%股份",
                        "7亿元"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "国企改革"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}